The incidence is creeping back up, however, and the first revelation is that it is proton pump inhibitors (PPIs) and immune checkpoint inhibitors (ICIs) that fuel the contemporary incidence of AIN, ...

Steroid treatment of acute interstitial nephritis (AIN) leads to greater improvement in estimated glomerular filtration rate (eGFR) and fewer patients progressing to end-stage renal disease (ESRD), ...

ORLANDO—Elderly patients have a higher incidence of drug-induced acute interstitial nephritis (AIN) than younger patients, according to study findings presented at the National Kidney Foundation’s ...

Acute interstitial nephritis (AIN) is an immunologically mediated condition that represents a significant cause of acute kidney injury (AKI). It is characterised by diffuse inflammatory infiltrates ...

A recent study posted to medRxiv* preprint server reported a novel form of post-acute coronavirus disease 2019 (COVID-19) syndrome in children. Study: Acute tubulointerstitial nephritis with or ...

Acute kidney injury is a known complication in patients receiving immunotherapy, but the reported incidence in clinical trials is only 2%-3% of patients. A higher incidence (up to 17%) has been ...

In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine test that can be used to diagnose acute ...

AKI can be classified as prerenal, intrinsic, or postrenal, with KDIGO criteria guiding diagnosis. New biomarkers like NGAL and cystatin C allow earlier and more precise detection of AKI. Preventing ...

There is great value, both for clinical trials and clinical practice, in biomarkers that identify patients at greatest risk of developing chronic kidney disease (CKD) after acute kidney injury, ...

Proton pump inhibitors (PPIs), widely prescribed for acid-related disorders like GERD and peptic ulcers, are associated with significant adverse effects when used long-term. This review highlights ...